Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.13)
# 2,741
Out of 4,711 analysts
401
Total ratings
36.39%
Success rate
-4.08%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PYXS Pyxis Oncology | Reiterates: Buy | $7 → $5 | $1.69 | +195.86% | 7 | Dec 20, 2024 | |
| PSNL Personalis | Maintains: Buy | $9 → $11 | $5.75 | +91.30% | 11 | Dec 20, 2024 | |
| ALXO ALX Oncology Holdings | Reiterates: Buy | $25 | $1.62 | +1,443.21% | 12 | Dec 18, 2024 | |
| ECOR electroCore | Maintains: Buy | $22 → $25 | $15.27 | +63.72% | 12 | Dec 18, 2024 | |
| BCYC Bicycle Therapeutics | Maintains: Buy | $55 → $33 | $14.68 | +124.80% | 16 | Dec 16, 2024 | |
| ABSI Absci | Reiterates: Buy | $7 | $2.99 | +134.11% | 10 | Dec 13, 2024 | |
| ELEV Elevation Oncology | Reiterates: Buy | $6 | $0.58 | +934.48% | 6 | Dec 13, 2024 | |
| ITOS iTeos Therapeutics | Reiterates: Buy | $21 | $7.42 | +183.02% | 9 | Dec 13, 2024 | |
| IPA ImmunoPrecise Antibodies | Maintains: Buy | $9 → $7 | $0.40 | +1,649.56% | 8 | Dec 11, 2024 | |
| VOR Vor Biopharma | Reiterates: Buy | $18 | $0.87 | +1,917.76% | 10 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.19 | +740.34% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.05 | +460.98% | 12 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $70 | $56.83 | +23.17% | 11 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.41 | +222.58% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $16.49 | +51.61% | 16 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 → $15 | $12.57 | +19.33% | 4 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.25 | +3,115.43% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.88 | +165.96% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5.5 | $1.30 | +323.08% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $12.46 | +116.69% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.76 | +424.52% | 8 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $2.91 | +89.00% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.69 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $1.5 | $0.61 | +145.38% | 12 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.77 | +804.04% | 17 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.50 | +766.67% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $23.80 | +68.07% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $11.01 | +99.82% | 10 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $56.50 | +6.19% | 16 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $0.92 | +1,421.74% | 9 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $51.40 | +55.64% | 17 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $9 | $0.58 | +1,451.46% | 12 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.19 | +767.58% | 13 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $0.95 | $0.63 | +50.79% | 4 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.89 | +85.19% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $9.10 | +20.88% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.76 | +624.64% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.48 | +936.05% | 5 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.16 | +116.35% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.96 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.28 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.03 | +773.79% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $2.33 | +972.96% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $9.45 | +58.73% | 1 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.05 | +143.90% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.24 | +1,602.13% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.65 | +352.83% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.69 | +2,788.92% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.98 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $2.02 | +3,860.40% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $4.99 | +20.24% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $4.40 | +240.91% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $4.19 | +687.59% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $9.35 | +1.60% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $6.50 | +215,284.62% | 1 | Mar 5, 2020 |
Pyxis Oncology
Dec 20, 2024
Reiterates: Buy
Price Target: $7 → $5
Current: $1.69
Upside: +195.86%
Personalis
Dec 20, 2024
Maintains: Buy
Price Target: $9 → $11
Current: $5.75
Upside: +91.30%
ALX Oncology Holdings
Dec 18, 2024
Reiterates: Buy
Price Target: $25
Current: $1.62
Upside: +1,443.21%
electroCore
Dec 18, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $15.27
Upside: +63.72%
Bicycle Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $55 → $33
Current: $14.68
Upside: +124.80%
Absci
Dec 13, 2024
Reiterates: Buy
Price Target: $7
Current: $2.99
Upside: +134.11%
Elevation Oncology
Dec 13, 2024
Reiterates: Buy
Price Target: $6
Current: $0.58
Upside: +934.48%
iTeos Therapeutics
Dec 13, 2024
Reiterates: Buy
Price Target: $21
Current: $7.42
Upside: +183.02%
ImmunoPrecise Antibodies
Dec 11, 2024
Maintains: Buy
Price Target: $9 → $7
Current: $0.40
Upside: +1,649.56%
Vor Biopharma
Dec 10, 2024
Reiterates: Buy
Price Target: $18
Current: $0.87
Upside: +1,917.76%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
Dec 9, 2024
Reiterates: Buy
Price Target: $12
Current: $2.05
Upside: +460.98%
Dec 3, 2024
Maintains: Buy
Price Target: $63 → $70
Current: $56.83
Upside: +23.17%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $3.41
Upside: +222.58%
Nov 27, 2024
Maintains: Buy
Price Target: $28 → $25
Current: $16.49
Upside: +51.61%
Nov 26, 2024
Reiterates: Buy
Price Target: $11 → $15
Current: $12.57
Upside: +19.33%
Nov 26, 2024
Reiterates: Buy
Price Target: $8
Current: $0.25
Upside: +3,115.43%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
Nov 21, 2024
Maintains: Buy
Price Target: $4 → $5.5
Current: $1.30
Upside: +323.08%
Nov 15, 2024
Reiterates: Buy
Price Target: $27
Current: $12.46
Upside: +116.69%
Nov 15, 2024
Reiterates: Buy
Price Target: $4
Current: $0.76
Upside: +424.52%
Nov 15, 2024
Reiterates: Buy
Price Target: $5.5
Current: $2.91
Upside: +89.00%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.69
Upside: -
Nov 14, 2024
Maintains: Buy
Price Target: $5 → $1.5
Current: $0.61
Upside: +145.38%
Nov 14, 2024
Reiterates: Buy
Price Target: $7
Current: $0.77
Upside: +804.04%
Nov 13, 2024
Reiterates: Buy
Price Target: $13
Current: $1.50
Upside: +766.67%
Nov 11, 2024
Reiterates: Buy
Price Target: $40
Current: $23.80
Upside: +68.07%
Nov 11, 2024
Reiterates: Buy
Price Target: $22
Current: $11.01
Upside: +99.82%
Nov 8, 2024
Reiterates: Buy
Price Target: $60
Current: $56.50
Upside: +6.19%
Nov 1, 2024
Reiterates: Buy
Price Target: $14
Current: $0.92
Upside: +1,421.74%
Oct 31, 2024
Reiterates: Buy
Price Target: $80
Current: $51.40
Upside: +55.64%
Oct 29, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $0.58
Upside: +1,451.46%
Aug 29, 2024
Reiterates: Buy
Price Target: $19
Current: $2.19
Upside: +767.58%
Aug 23, 2024
Downgrades: Neutral
Price Target: $3 → $0.95
Current: $0.63
Upside: +50.79%
Aug 13, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.89
Upside: +85.19%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $9.10
Upside: +20.88%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.76
Upside: +624.64%
Mar 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.48
Upside: +936.05%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $4.16
Upside: +116.35%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.96
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $5.28
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.03
Upside: +773.79%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $2.33
Upside: +972.96%
Jan 4, 2023
Initiates: Buy
Price Target: $15
Current: $9.45
Upside: +58.73%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.05
Upside: +143.90%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.24
Upside: +1,602.13%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.65
Upside: +352.83%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.69
Upside: +2,788.92%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $17.98
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $2.02
Upside: +3,860.40%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $4.99
Upside: +20.24%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $4.40
Upside: +240.91%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $4.19
Upside: +687.59%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $9.35
Upside: +1.60%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $6.50
Upside: +215,284.62%